• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高剂量血管加压素和皮质类固醇联合用于一名克罗恩病患者,该患者在肠穿孔后发生难治性感染性休克:一例病例报告。

Combined use of high doses of vasopressin and corticosteroids in a patient with Crohn's disease with refractory septic shock after intestinal perforation: a case report.

作者信息

Notaro Salvatore, Sorrentino Marcello, Ruocco Aniello, Notaro Annalisa, Corcione Antonio, Murino Patrizia, Piscitelli Eugenio, Tamborino Marianna

机构信息

Intensive Care Unit, AORN dei colli Vincenzo Monaldi Hospital, Naples, Italy.

Intensive Care Unit, Fatebenefratelli Hospital, Naples, Italy.

出版信息

J Med Case Rep. 2017 Nov 13;11(1):320. doi: 10.1186/s13256-017-1456-3.

DOI:10.1186/s13256-017-1456-3
PMID:29129185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5682640/
Abstract

BACKGROUND

In this article, we present a clinical case of refractory septic shock resulting from intestinal perforation treated with high doses of vasopressin and hydrocortisone during emergency surgery. The use of such high doses of vasopressin for this type of shock is not described in the literature.

CASE PRESENTATION

A 49-year-old white woman with grade III obesity, Crohn's disease, and an intestinal perforation presented with refractory septic shock. Initially, a low dose of vasopressin was used. Then, the dosage was increased to 0.4 U/minute; in the literature, this is defined as "salvage therapy." This therapy consists of an initial load followed by a continuous infusion of hydrocortisone.

CONCLUSIONS

The significant increase in her cardiac index and stroke volume index resulted in an improvement in peripheral resistance, gas exchange, and urine output and a decrease in her heart rate, interleukin-6 level, and tumor necrosis factor-α level. The administration of high doses of vasopressin and corticosteroids was demonstrated to be safe for the immune system, to reduce the systemic inflammatory response, and to have direct cardiovascular effects. Further studies are required to examine the use of vasopressin as an initial vasopressor as well as its use in high dosages and in combination with corticosteroids.

摘要

背景

在本文中,我们介绍了一例因肠穿孔导致的难治性感染性休克的临床病例,该病例在急诊手术期间接受了高剂量血管加压素和氢化可的松治疗。文献中未描述将如此高剂量的血管加压素用于此类休克的情况。

病例介绍

一名49岁的白人女性,患有III级肥胖症、克罗恩病和肠穿孔,出现难治性感染性休克。最初使用了低剂量的血管加压素。然后,剂量增加至0.4 U/分钟;在文献中,这被定义为“挽救治疗”。该治疗包括初始负荷剂量,随后持续输注氢化可的松。

结论

她的心脏指数和每搏输出量指数显著增加,导致外周阻力、气体交换和尿量改善,心率、白细胞介素-6水平和肿瘤坏死因子-α水平降低。高剂量血管加压素和皮质类固醇的给药被证明对免疫系统安全,可减轻全身炎症反应,并具有直接的心血管作用。需要进一步研究血管加压素作为初始血管升压药的使用情况,以及其高剂量使用和与皮质类固醇联合使用的情况。

相似文献

1
Combined use of high doses of vasopressin and corticosteroids in a patient with Crohn's disease with refractory septic shock after intestinal perforation: a case report.高剂量血管加压素和皮质类固醇联合用于一名克罗恩病患者,该患者在肠穿孔后发生难治性感染性休克:一例病例报告。
J Med Case Rep. 2017 Nov 13;11(1):320. doi: 10.1186/s13256-017-1456-3.
2
Effects of continuous vasopressin infusion in patients with septic shock.持续输注血管加压素对感染性休克患者的影响。
Ann Pharmacother. 2004 Jul-Aug;38(7-8):1117-22. doi: 10.1345/aph.1D513. Epub 2004 Jun 3.
3
Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.皮质类固醇对脓毒性休克患者使用含精氨酸加压素血管升压药治疗的影响:一项病例对照研究。
J Crit Care. 2008 Dec;23(4):500-6. doi: 10.1016/j.jcrc.2008.04.002. Epub 2008 Jun 30.
4
The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.血管加压素和皮质类固醇在感染性休克中的相互作用:一项初步随机对照试验。
Crit Care Med. 2014 Jun;42(6):1325-33. doi: 10.1097/CCM.0000000000000212.
5
Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.在难治性感染性休克中,同时使用血管加压素和氢化可的松治疗对短期血流动力学效应和血管加压药需求的影响。
J Crit Care. 2017 Dec;42:6-11. doi: 10.1016/j.jcrc.2017.06.016. Epub 2017 Jun 17.
6
Low-dose vasopressin in the treatment of septic shock in sheep.低剂量血管加压素治疗绵羊感染性休克
Am J Respir Crit Care Med. 2003 Aug 15;168(4):481-6. doi: 10.1164/rccm.200205-447OC. Epub 2003 Jun 5.
7
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.血管加压素输注、皮质类固醇治疗与感染性休克死亡率之间的相互作用。
Crit Care Med. 2009 Mar;37(3):811-8. doi: 10.1097/CCM.0b013e3181961ace.
8
Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?体重会影响血管加压素治疗脓毒性休克的疗效吗?
J Crit Care. 2012 Jun;27(3):289-93. doi: 10.1016/j.jcrc.2011.06.018. Epub 2011 Aug 19.
9
Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension--a case report.小剂量血管加压素输注可作为治疗难治性感染性休克合并慢性肺动脉高压患者的一种替代方法——病例报告
Acta Anaesthesiol Sin. 2003 Jun;41(2):77-80.
10
The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy.接受血管加压素治疗的日本儿茶酚胺抵抗性感染性休克患者的长期生存率。
Clin Nephrol. 2009 Aug;72(2):129-36. doi: 10.5414/cnp72129.

引用本文的文献

1
Association Between Different DVT Prevention Methods and Outcomes of Septic Shock Caused by Intestinal Perforation in China: A Cross-Sectional Study.中国不同深静脉血栓形成预防方法与肠穿孔所致感染性休克结局的关联:一项横断面研究
Front Med (Lausanne). 2022 Apr 27;9:878075. doi: 10.3389/fmed.2022.878075. eCollection 2022.
2
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19).白细胞介素 6 信号阻断在严重 2019 年冠状病毒病(COVID-19)中的最新进展、挑战和临床考虑的更新概述。
Int Immunopharmacol. 2022 Apr;105:108536. doi: 10.1016/j.intimp.2022.108536. Epub 2022 Jan 11.

本文引用的文献

1
Phosphoinositide 3-Kinase Is Involved in Mediating the Anti-inflammation Effects of Vasopressin.磷酸肌醇 3-激酶参与介导血管加压素的抗炎作用。
Inflammation. 2017 Apr;40(2):435-441. doi: 10.1007/s10753-016-0489-x.
2
Effects of Systemically Administered Hydrocortisone on the Human Immunome.全身应用氢化可的松对人类免疫组的影响。
Sci Rep. 2016 Mar 14;6:23002. doi: 10.1038/srep23002.
3
Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).血管加压素与去甲肾上腺素作为感染性休克初始治疗的随机对照试验方案(VANISH)
BMJ Open. 2014 Jul 3;4(7):e005866. doi: 10.1136/bmjopen-2014-005866.
4
Early vasopressin reduces incidence of new onset arrhythmias.早期使用血管加压素可降低新发心律失常的发生率。
J Crit Care. 2014 Aug;29(4):482-5. doi: 10.1016/j.jcrc.2014.03.005. Epub 2014 Mar 22.
5
The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.血管加压素和皮质类固醇在感染性休克中的相互作用:一项初步随机对照试验。
Crit Care Med. 2014 Jun;42(6):1325-33. doi: 10.1097/CCM.0000000000000212.
6
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南:2012 年。
Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.
7
Bench-to-bedside review: Vasopressin in the management of septic shock.从临床前到临床:血管加压素在脓毒性休克治疗中的应用。
Crit Care. 2011 Aug 11;15(4):226. doi: 10.1186/cc8224.
8
Vasopressin and its immune effects in septic shock.血管加压素及其在感染性休克中的免疫作用。
J Innate Immun. 2010;2(5):446-60. doi: 10.1159/000318531. Epub 2010 Jul 5.
9
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.血管加压素输注、皮质类固醇治疗与感染性休克死亡率之间的相互作用。
Crit Care Med. 2009 Mar;37(3):811-8. doi: 10.1097/CCM.0b013e3181961ace.
10
Vasopressin versus norepinephrine infusion in patients with septic shock.脓毒性休克患者中血管加压素与去甲肾上腺素输注的比较。
N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.